Clinical Trials
8 trialsNCT02359565 2026-05-13
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT00662506 2023-06-06
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT02903784 2020-09-02
BNL
University Hospital, Montpellier
Phase NA Completed
NCT02277561 2020-03-04
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
Albert Einstein College of Medicine
Phase NA Withdrawn
NCT00330109 2017-01-16
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
AHS Cancer Control Alberta
Phase NA Unknown
NCT02006407 2016-12-30
A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors
University of Michigan Rogel Cancer Center
Phase NA Terminated
NCT01549392 2014-09-15
Imaging Study of Glioblastomas Treated With Avastin
London Health Sciences Centre
Phase NA Terminated
NCT01018329 2012-12-11
Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma
Abramson Cancer Center at Penn Medicine
Phase NA Completed